Google Search Trends About Systemic Psoriasis Treatment: What Do People Want to Know About Biologics and Janus Kinase Inhibitors?

According to data on advertisement expenses, AbbVie allocated almost US $500 million toward advertising adalimumab in 2020, while roughly half of that amount (US $202 million) was dedicated to promoting risankizumab. Category Description Internet sources (n=782), n (%) Average source quality score (out of 4) Commercial Commercial organization that positions itself as a source of health information, includes medical device and pharmaceutical companies (eg, Healthline, WebMD) 362 (46.3) 3.1 Academic Institution with a clear academic mandate, including universities, academic medical centers, academic societies, and journals (eg, Mayo Clinic) 98 (12.5) 2.3 Government Websites ending in .gov or maintained by a national government (eg, PubMed) 119 (15.2) 3.2 Medical practice Local hospital or dermatology practices without an academic affiliation 12 (1.5) 1 Social media Websites maintained by nonmedical organizations primarily designed for information sharing between internet users, including health blogs, internet forums, and support groups 191 (24.4) 2.1 Discussion Our analyses indicate that users are being directed to commercial and government-based websites most often when seeking information about psoriasis treatment. [...]although individual medical practice websites were not referred to as often, they scored only 1 out of 4 on average, indicating an area for improvement both for these practices and the search engine.